What we choose to study—whether fine art or finance—is one of the most influential decisions in our lives. It shapes not only ...
In the largest genetic analysis of polycystic ovary syndrome to date, scientists have identified new variants linked to the ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.
A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve ...
December 6 - 9, 2025. "The data we’re presenting at this year’s ASH meeting reflect the strong momentum of our in vivo programs for sickle cell disease (SCD) and T-cell engineering,” said Michael ...
They're exploring its use for groundbreaking treatments for cancer and autoimmune disease, as well as for gene-editing ...
Q3 2025 Earnings Call Transcript October 29, 2025 BridgeBio Pharma, Inc. misses on earnings expectations. Reported EPS is $-0 ...
On a chilly April morning, Travis Gienger took his first gamble of the 2025 season. The world-champion giant-pumpkin grower ...
On a chilly April morning, Travis Gienger took his first gamble of the 2025 season. The world-champion giant-pumpkin grower ...
Beam Therapeutics Inc. trades at a relatively cheap valuation based on its multiples and potential in SCD. Learn more about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback